Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

Agreed, but a little confused about specifically what Leo was saying here:

"This new financing serves to further bolster our balance sheet and gives us flexibility in working to meet our near-term goals, which includes advancing Brilacidin into a pivotal study," said Leo Ehrlich, Chief Executive Officer of Innovation Pharmaceuticals. "The Company is at an exciting juncture, with our three novel drug candidates successfully reaching mid- and later-stage trials across multiple indications representing large market opportunities. We remain steadfast in delivering innovative medicines to patients and increasing the Company's valuation."

P3 for the indications we're 'expecting', would be beyond the scope of a $10M cash infusion, including all existing overhead. So what the hell is he referencing?

Leo would need additional funding if BP's upfront payment is either restricted to OM/UP or falls below the estimated costs to further develop P/K and B... Most likely, today's deal was needed either way... What a partnership should accomplish is rally the shares to make financing more attainable.

There hasn't been any further reference of a partnership or the 'term sheet' we saw mentioned in the 10-K. Do we think its been burned?

Why can't they just be tranparent here, and actually let shareholders know what they're doing with our cash? Why so cryptic all the time? I get it with 'active CDA's', but if nothing's happening, then just let us know. Believe it or not, when you're transparent and actually NEED help, help can be found!